SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-21-014711
Filing Date
2021-03-11
Accepted
2021-03-11 07:36:12
Documents
5
Effectiveness Date
2021-03-11

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea137341-s8_protaratherap.htm S-8 63872
2 OPINION OF COOLEY LLP. ea137341ex5-1_protara.htm EX-5.1 9836
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea137341ex23-1_protara.htm EX-23.1 3017
4 GRAPHIC image_001.jpg GRAPHIC 2953
5 GRAPHIC image_002.jpg GRAPHIC 2953
  Complete submission text file 0001213900-21-014711.txt   86351
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254124 | Film No.: 21731866
SIC: 2836 Biological Products, (No Diagnostic Substances)